EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Preoperative radiosurgery for brain metastases (PREOP-1): A feasibility trial

S Rogers, L Schwyzer, N Lomax, S Alonso, T Lazeroms, S Gomez, K Diahovets, I Fischer, S Schwenne, A Ademaj, S Berkmann, A Tortora und 4 weitere

Clinical and Translational Radiation Oncology · 2024-07 · 47 · 100798

DOI: 10.1016/j.ctro.2024.100798 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Radiation Oncology, 2024-07. Verfasst von S Rogers und 15 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology Centre KSA-KSB, Kantonsspital Aarau, Tellstrasse, 5001 Aarau, Switzerland. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Preoperative radiosurgery (SRS) of brain metastases (BM) aims to achieve cavity local control with a reduction in leptomeningeal relapse (LMD) and without additional radionecrosis compared to postoperative SRS. We present the final results of a prospective feasibility trial of linac-based stereotactic radiosurgery (SRS) prior to neurosurgical resection of a brain metastasis (PREOP-1).

Methods

Eligibility criteria included a BM up to 4 cm in diameter for elective resection. The primary endpoint was the feasibility of delivering linac-based preoperative SRS in all patients prior to anticipated gross tumour resection. Secondary endpoints included rates of LMD, local control and overall survival. Exploratory endpoints were the level of expression of immunological and proliferative markers.

Results

Thirteen patients of median age 65 years (range 41-77) were recruited. Twelve patients (92 %) received preoperative radiosurgery and metastasectomy and one patient went directly to surgery and received postoperative SRS, thus the primary endpoint was not met. The median time between referral and preoperative SRS was 6.5 working days (1-10) and from SRS to neurosurgery was 1 day (0-5). The median prescribed dose was 16 Gy (14-19) to a median planning target volume of 12.7 cm3 (5.9-26.1). Five patients completed 12-month follow-up after preoperative SRS without local recurrence or leptomeningeal disease. The patient who received postoperative FSRT developed LMD after six months. There was one transient toxicity (grade 2 alopecia) and nine patients have died from extracranial causes. Patients reported significant improvement in motor weakness at 6 months (P = 0.04). No pattern in changes of marker expression was observed.

Conclusion

In patients with large brain metastasis without raised intracranial pressure, linac-based preoperative SRS was feasible in 12/13 patients and safe in 12/12 patients without any surgical delay or intracranial complications.

Schlagwörter

Stichwörter der Autor:innen

BrainFeasibilityMetastasesPreoperativeRadiosurgeryTrial

Autor:innen und Institutionen

  • Radiation Oncology Centre KSA-KSB, Kantonsspital Aarau, Tellstrasse, 5001 Aarau, Switzerland.
  • Dept. of Neurosurgery, Kantonsspital Aarau, Tellstrasse, 5001 Aarau, Switzerland.
  • Dept. of Neuropathology, Kantonsspital Aarau, Tellstrasse, 5001 Aarau, Switzerland.
  • Doctoral Clinical Science Program, Medical Faculty, University of Zürich, 8032 Zürich, Switzerland.
  • Neurochirurgie Baden, Husmatt 1, 5405 Baden, Switzerland.
  • Dept. of Neurosurgery, Presidio Ospedaliero Universitario Santa Maria Della Misericordia Udine, Italy.

Zitieren

APA

Rogers, S., Schwyzer, L., Lomax, N., Alonso, S., Lazeroms, T., Gomez, S., Diahovets, K., Fischer, I., Schwenne, S., Ademaj, A., Berkmann, S., Tortora, A., Marbacher, S., Remonda, L., Schubert, G. A., & Riesterer, O. (2024). Preoperative radiosurgery for brain metastases (PREOP-1): A feasibility trial. Clinical and Translational Radiation Oncology, 47, 100798. https://doi.org/10.1016/j.ctro.2024.100798

Vancouver

Rogers S, Schwyzer L, Lomax N, Alonso S, Lazeroms T, Gomez S, et al. Preoperative radiosurgery for brain metastases (PREOP-1): A feasibility trial. Clinical and Translational Radiation Oncology. 2024;47:100798. doi:10.1016/j.ctro.2024.100798

BibTeX
@article{Rogers2024,
  author = {Rogers, S and Schwyzer, L and Lomax, N and Alonso, S and Lazeroms, T and Gomez, S and Diahovets, K and Fischer, I and Schwenne, S and Ademaj, A and Berkmann, S and Tortora, A and Marbacher, S and Remonda, L and Schubert, G A and Riesterer, O},
  title = {Preoperative radiosurgery for brain metastases (PREOP-1): A feasibility trial},
  journal = {Clinical and Translational Radiation Oncology},
  year = {2024},
  volume = {47},
  pages = {100798},
  doi = {10.1016/j.ctro.2024.100798}
}
Kostenlos starten →